| 2.5 0.03 (1.21%) | 09-10 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 3.17 | 1-year : | 3.71 |
| Resists | First : | 2.72 | Second : | 3.17 |
| Pivot price | 2.39 |
|||
| Supports | First : | 2.35 | Second : | 2.13 |
| MAs | MA(5) : | 2.46 |
MA(20) : | 2.37 |
| MA(100) : | 2.35 |
MA(250) : | 2.32 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 80.8 |
D(3) : | 77.5 |
| RSI | RSI(14): 57.1 |
|||
| 52-week | High : | 3.11 | Low : | 1.97 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ KRMD ] has closed below upper band by 22.3%. Bollinger Bands are 18.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 2.55 - 2.56 | 2.56 - 2.57 |
| Low: | 2.41 - 2.42 | 2.42 - 2.43 |
| Close: | 2.48 - 2.5 | 2.5 - 2.52 |
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Fri, 06 Sep 2024
Here's Why We're Not At All Concerned With KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Situation - Yahoo Finance
Thu, 05 Sep 2024
KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference - StockTitan
Sun, 01 Sep 2024
KORU Medical Systems, Inc. (NASDAQ:KRMD) Short Interest Update - MarketBeat
Thu, 29 Aug 2024
We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow - Simply Wall St
Sat, 10 Aug 2024
Analysts Are Updating Their KORU Medical Systems, Inc. (NASDAQ:KRMD) Estimates After Its Second-Quarter Results - Yahoo Finance
Thu, 08 Aug 2024
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q2 2024 Earnings Call Transcript - Insider Monkey
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 46 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 6.4 (%) |
| Held by Institutions | 54.6 (%) |
| Shares Short | 215 (K) |
| Shares Short P.Month | 469 (K) |
| EPS | -0.25 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.4 |
| Profit Margin | -38.2 % |
| Operating Margin | -14.2 % |
| Return on Assets (ttm) | -14.2 % |
| Return on Equity (ttm) | -50.3 % |
| Qtrly Rev. Growth | 21.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.67 |
| EBITDA (p.s.) | -0.14 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 1 (M) |
| PE Ratio | -10 |
| PEG Ratio | 0 |
| Price to Book value | 6.09 |
| Price to Sales | 3.71 |
| Price to Cash Flow | -277.33 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|